Recruiting Pulmonary Fibrosis Studies in Phoenix
About Pulmonary Fibrosis Clinical Trials in Phoenix
Pulmonary fibrosis is a condition in which the lung tissue becomes damaged and scarred, making it difficult for the lungs to function properly. Idiopathic pulmonary fibrosis (IPF) is the most common form with unknown cause. Antifibrotic medications can slow progression, and lung transplant may be considered.
There are currently 3 pulmonary fibrosis clinical trials recruiting participants in Phoenix, AZ. These studies are seeking a combined 1,221 participants. Research is being sponsored by United Therapeutics, AstraZeneca, Mediar Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Fibrosis Clinical Trials in Phoenix — FAQ
Are there pulmonary fibrosis clinical trials in Phoenix?
Yes, there are 3 pulmonary fibrosis clinical trials currently recruiting in Phoenix, AZ. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Phoenix?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you about next steps.
Are clinical trials in Phoenix free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Phoenix studies also compensate for your time and travel.
What pulmonary fibrosis treatments are being tested?
The 3 active trials in Phoenix are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary fibrosis.
Data updated July 22, 2026 from ClinicalTrials.gov